Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study to Determine the Safety and Immunogenicity of a Sublingual Administration of NSV0001 in Healthy Male Volunteers

NCT02955030 is registered in ClinicalTrials.gov with Nitto Denko Corporation as lead sponsor.

NCT NCT02955030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02955030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study to Determine the Safety and Immunogenicity of a Sublingual Administration of NSV0001 in Healthy Male Volunteers
Lead sponsor
Nitto Denko Corporation
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2016
Completion date
September 30, 2017
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza